Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Blood
|
July 29, 2010
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
Kimberly Noonan, Luigi Marchionni, Judy Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Tumor-Specific CD8<sup>+</sup> T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes
Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, et al.
Blood
|
December 8, 2007
Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation
Paria Mirmonsef, Gladys Tan, Gang Zhou, et al.
Hematology. American Society of Hematology. Education Program
|
November 10, 2001
New Developments in the Therapy of Acute Myelocytic Leukemia
Norbert C. Gorin, Elihu Estey, Richard J. Jones, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Tumor-specific CD8<sup>+</sup> T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes
Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses
Kimberly Noonan, Lakshmi Rudraraju, Anna Ferguson, et al.
Blood
|
December 13, 2005
In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity
Pedro Horna, Alex Cuenca, Fengdong Cheng, et al.
Plos One
|
December 1, 2017
Flow cytometric discrimination of seven lineage markers by using two fluorochromes
Francesco Boin, Maria Letizia Giardino Torchia, Ivan Borrello, et al.
The Journal of Experimental Medicine
|
November 15, 2006
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini, Kristen Meckel, Michael Kelso, et al.
Leukemia
|
July 1, 2020
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
Philippe Armand, Alexander Lesokhin, Ivan Borrello, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Blood
|
July 29, 2010
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
Kimberly Noonan, Luigi Marchionni, Judy Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Tumor-Specific CD8<sup>+</sup> T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes
Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, et al.
Blood
|
December 8, 2007
Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation
Paria Mirmonsef, Gladys Tan, Gang Zhou, et al.
Hematology. American Society of Hematology. Education Program
|
November 10, 2001
New Developments in the Therapy of Acute Myelocytic Leukemia
Norbert C. Gorin, Elihu Estey, Richard J. Jones, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Tumor-specific CD8<sup>+</sup> T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes
Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses
Kimberly Noonan, Lakshmi Rudraraju, Anna Ferguson, et al.
Blood
|
December 13, 2005
In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity
Pedro Horna, Alex Cuenca, Fengdong Cheng, et al.
Plos One
|
December 1, 2017
Flow cytometric discrimination of seven lineage markers by using two fluorochromes
Francesco Boin, Maria Letizia Giardino Torchia, Ivan Borrello, et al.
The Journal of Experimental Medicine
|
November 15, 2006
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini, Kristen Meckel, Michael Kelso, et al.
Leukemia
|
July 1, 2020
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
Philippe Armand, Alexander Lesokhin, Ivan Borrello, et al.
Page
of 9